A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.
Open Access
- 1 March 1989
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 83 (3) , 757-763
- https://doi.org/10.1172/jci113954
Abstract
The NADPH:O2 oxidoreductase (NADPH oxidase) of human neutrophils is converted from a dormant to an active state upon stimulation of the cells. We have studied the soluble fraction that is required for NADPH oxidase activation in a cell-free system. Human neutrophils were separated in a membrane-containing and a soluble fraction. The soluble fraction was separated on carboxymethyl (CM) Sepharose in 10 mM 4-morpholino-ethanesulfonic acid buffer of pH 6.8. Reconstitution of the NADPH oxidase activity, measured as O2 consumption, was only found when the membrane fraction was combined with the flowthrough of the CM Sepharose column as well as with a fraction that eluted at 125 mM NaCl. This result indicates that at least two soluble components are necessary for reconstitution of the NADPH oxidase activity: one that does not bind to CM Sepharose and one that does bind. These components were designated soluble oxidase component (SOC) I and SOC II, respectively. Boiling destroyed the activity in both fractions. In the soluble fraction of human lymphocytes and thrombocytes neither SOC I nor SOC II activity was found. SOC II copurified with a 47-kD phosphoprotein, previously found defective in patients with the autosomal form of chronic granulomatous disease (CGD). Inactive soluble fractions of cells from autosomal CGD patients were reconstituted with a SOC II fraction from control cells. The result of this experiment indicates that autosomal CGD patients are normal in SOC I but defective in SOC II.This publication has 32 references indexed in Scilit:
- Chronic granulomatous disease due to a defect in the cytosolic factor required for nicotinamide adenine dinucleotide phosphate oxidase activation.Journal of Clinical Investigation, 1988
- Reversible activation of NADPH oxidase in membranes of HL-60 human leukemic cellsBiochemical and Biophysical Research Communications, 1987
- Cell-free activation of phagocyte NADPH-oxidase: Tissue and differentiation-specific expression of cytosolic cofactor activityBiochemical and Biophysical Research Communications, 1987
- The O2−-forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and functionBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1986
- Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system.Journal of Clinical Investigation, 1985
- Activation of protein kinase C in neutrophil cytoplastsFEBS Letters, 1985
- Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous diseaseNature, 1984
- Biological Defense Mechanisms. THE PRODUCTION BY LEUKOCYTES OF SUPEROXIDE, A POTENTIAL BACTERICIDAL AGENTJournal of Clinical Investigation, 1973
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Leukocyte Oxidase: Defective Activity in Chronic Granulomatous DiseaseScience, 1967